These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28699816)

  • 1. Enrichment of Ly6C
    Zhao W; Zhou X; Zhao G; Lin Q; Wang X; Yu X; Wang B
    Hum Vaccin Immunother; 2017 Dec; 13(12):2872-2882. PubMed ID: 28699816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-α as an effective therapeutic vaccine adjuvant.
    Zhao W; Zhao G; Zhang S; Wang X; Yu X; Wang B
    Oncotarget; 2018 Sep; 9(76):34213-34228. PubMed ID: 30344938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells.
    Chou HY; Lin XZ; Pan WY; Wu PY; Chang CM; Lin TY; Shen HH; Tao MH
    J Immunol; 2010 Nov; 185(9):5468-75. PubMed ID: 20889541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
    Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
    Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte Antigen 6 Complex, Locus C
    Wu LL; Peng WH; Wu HL; Miaw SC; Yeh SH; Yang HC; Liao PH; Lin JS; Chen YR; Hong YT; Wang HY; Chen PJ; Chen DS
    Hepatology; 2019 Jun; 69(6):2364-2380. PubMed ID: 30661248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients.
    Verkade MA; van de Wetering J; Klepper M; Vaessen LM; Weimar W; Betjes MG
    Kidney Int; 2004 Aug; 66(2):614-21. PubMed ID: 15253714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
    Kapoor D; Aggarwal SR; Singh NP; Thakur V; Sarin SK
    J Viral Hepat; 1999 Sep; 6(5):405-9. PubMed ID: 10607257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
    Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
    Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
    Wang G; Dong XY; Tian WH; Yu CJ; Zheng G; Gao J; Wang GJ; Wei GC; Zhou YS; Wu XB
    Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
    Overton ET; Kang M; Peters MG; Umbleja T; Alston-Smith BL; Bastow B; Demarco-Shaw D; Koziel MJ; Mong-Kryspin L; Sprenger HL; Yu JY; Aberg JA
    Vaccine; 2010 Aug; 28(34):5597-604. PubMed ID: 20600512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice.
    Backes S; Jäger C; Dembek CJ; Kosinska AD; Bauer T; Stephan AS; Dišlers A; Mutwiri G; Busch DH; Babiuk LA; Gasteiger G; Protzer U
    Vaccine; 2016 Feb; 34(7):923-32. PubMed ID: 26776470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of an HBV DNA vaccine by fusion of the GM-CSF gene to the HBV-S gene and examination of its immune effects in normal and HBV-transgenic mice.
    Qing Y; Chen M; Zhao J; Hu H; Xu H; Ling N; Peng M; Ren H
    Vaccine; 2010 Jun; 28(26):4301-7. PubMed ID: 20430121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice.
    Horng JH; Lin WH; Wu CR; Lin YY; Wu LL; Chen DS; Chen PJ
    J Biomed Sci; 2020 May; 27(1):70. PubMed ID: 32466788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.
    Jha R; Lakhtakia S; Jaleel MA; Narayan G; Hemlatha K
    Ren Fail; 2001 Sep; 23(5):629-36. PubMed ID: 11725909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.